BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 10955331)

  • 1. Clinical course of primary Sjögren's syndrome: salivary, oral, and serologic aspects.
    Gannot G; Lancaster HE; Fox PC
    J Rheumatol; 2000 Aug; 27(8):1905-9. PubMed ID: 10955331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective studies on the progress of sicca symptoms in Sjögren's syndrome: subclinical disease develops into the clinical syndrome.
    Ichikawa Y; Takaya M; Uchiyama M; Shimizu H; Tokunaga M; Saitoh H; Arimori S
    Tokai J Exp Clin Med; 1988 Jun; 13(2):85-90. PubMed ID: 3250005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term follow-up of 43 patients with Sjögren's syndrome].
    Cui G; Sugai S; Ogawa Y; Takeshita S; Masaki Y; Fukutoku M
    Ryumachi; 1997 Dec; 37(6):770-80. PubMed ID: 9492564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome.
    Vissink A; Kalk WW; Mansour K; Spijkervet FK; Bootsma H; Roodenburg JL; Kallenberg CG; Nieuw Amerongen AV
    Arch Otolaryngol Head Neck Surg; 2003 Sep; 129(9):966-71. PubMed ID: 12975269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to AB blood group antigens mimic anti-salivary duct autoantibodies in patients with limited sicca symptoms.
    Goldblatt F; Beroukas D; Gillis D; Cavill D; Bradwell A; Rischmueller M; Gordon TP
    J Rheumatol; 2000 Oct; 27(10):2382-8. PubMed ID: 11036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI; Dixon R; Guarrasi V; Krubel S
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of salivary gland hypofunction in primary and secondary Sjögren's syndrome.
    Dawson LJ; Holt DJ; Higham SM; Longman LP; Field EA
    Oral Dis; 2001 Jan; 7(1):28-30. PubMed ID: 11354918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sjögren's syndrome in progressive systemic sclerosis.
    Drosos AA; Andonopoulos AP; Costopoulos JS; Stavropoulos ED; Papadimitriou CS; Moutsopoulos HM
    J Rheumatol; 1988 Jun; 15(6):965-8. PubMed ID: 3418646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients.
    Avouac J; Sordet C; Depinay C; Ardizonne M; Vacher-Lavenu MC; Sibilia J; Kahan A; Allanore Y
    Arthritis Rheum; 2006 Jul; 54(7):2243-9. PubMed ID: 16802363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of major salivary gland ultrasonography in primary Sjögren's syndrome.
    Hammenfors DS; Brun JG; Jonsson R; Jonsson MV
    Clin Exp Rheumatol; 2015; 33(1):56-62. PubMed ID: 25535773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of screening tests for Sjögren's syndrome in ambulatory patients with chronic diseases.
    Sánchez-Guerrero J; Pérez-Dosal MR; Celis-Aguilar E; Cárdenas-Velázquez F; Soto-Rojas AE; Avila-Casado C
    J Rheumatol; 2006 May; 33(5):907-11. PubMed ID: 16541477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral and ocular manifestations in Sjögren's syndrome.
    Kalk WW; Mansour K; Vissink A; Spijkervet FK; Bootsma H; Kallenberg CG; Roodenburg JL; Nieuw Amerongen AV
    J Rheumatol; 2002 May; 29(5):924-30. PubMed ID: 12022351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of Sjögren's syndrome.
    Mavragani CP; Moutsopoulos NM; Moutsopoulos HM
    Nat Clin Pract Rheumatol; 2006 May; 2(5):252-61. PubMed ID: 16932698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of palatal saliva flow rate and oral manifestations in patients with Sjögren's syndrome.
    Márton K; Boros I; Varga G; Zelles T; Fejérdy P; Zeher M; Nagy G
    Oral Dis; 2006 Sep; 12(5):480-6. PubMed ID: 16910919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread pain and Sjögren's syndrome.
    Pendarvis WT; Pillemer SR
    J Rheumatol; 2001 Dec; 28(12):2657-9. PubMed ID: 11764213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological findings consistent with primary Sjögren's syndrome in a subset of patients diagnosed with chronic fatigue syndrome: preliminary observations.
    Sirois DA; Natelson B
    J Rheumatol; 2001 Jan; 28(1):126-31. PubMed ID: 11196514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sjögren's syndrome in dermatology.
    Fox RI; Liu AY
    Clin Dermatol; 2006; 24(5):393-413. PubMed ID: 16966020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.